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In addition  to the chemical  and  physical  studies  (2, 3)  which form  the
basis  for  the  recognition  of  antibodies  as  modified  globulins,  there  have
been numerous investigations  on the antigenic  behavior of  antibodies and
their  relation  to  the  normal  serum  globulins.  For  example,  Braun  (4)
demonstrated  the  ability  of  bacteria  agglutinated  with  horse  serum  to
sensitize  guinea  pigs  to  the  latter.  Landsteiner  and  Prasek  (5)  showed
that precipitins for horse serum would remove agglutinins from antityphoid
horse  sera.  More  recently,  antibodies  have been  produced  by immuniza-
tion  with  specific  precipitates  (6,  7).  In  their  use  non-specific  protein
may  be  removed  by thorough  washing,  leaving  relatively  pure  antibody
for injection,  especially in those instances  in which pneumococcus  polysac-
charides are used to precipitate  the antibody.  It  will be recalled  (8)  that
these polysaccharides  are  non-antigenic  in  the rabbit.
In  a  comprehensive  series  of  immunological  papers  (6)  Ando  and  his
coworkers have demonstrated  that two antigenic fractions of horse  serum,
designated  A  and  B,  are  related  to  antibodies.  The  antitoxic  globulins
constitute  a part of the A  fraction,  and the antibacterial  antibodies  (with
the  probable  exception  of  the  Shiga  dysentery  anticarbohydrate)  belong
to the B group.  By absorption  tests and  other methods it was  concluded
that  typhoidal,  plague,  and  Type  I pneumococcal  antibodies  from horse
sera  are  almost,  if  not  completely  identical  as  antigens.  Although  their
investigation  was  primarily  undertaken  to  see  whether  euglobulin  and
pseudoglobulin  occur  as  such  in  whole  horse  serum,  Marrack  and  Duff
(7) have  also  tested a  number  of  different  horse  serum  fractions  and  a
purified antibody solution against an anti-specific precipitate rabbit serum.
* The  work  reported  in  this  communication  was  carried  out  under  the  Harkness
Research Fund of the Presbyterian Hospital.
t Presented in part before the Society of American Bacteriologists  at  the New Haven
meeting,  December, 1939  (1).
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The  present  investigation  was  undertaken  to  examine  more  fully  the
utility of specific precipitates both as immunizing and as test antigens in an
adaptation  of  the  quantitative  agglutinin  method  (9)  developed  in  this
laboratory.  Quantitative  information  was  desired  on  the  chemical  rela-
tions not only of  antibodies  to the  different  serological  types  of  pneumo-
coccus,  but  also  of  antibodies  directed  against  a somatic  component,  the
so  called  C  polysaccharide  of  the  pneumococcal  cell.  Informationwas
also  desired  on  pepsin-digested  antibody.  Accordingly,  a  specific  pre-
cipitate derived  from antipneumococcus  Type II  horse serum was  used  as
antigen  for  the injection  of  rabbits and  the  resulting  sera  were  tested  as
described  below.
Methods and Materials
Preparation  of the Immunizing Antigen Suspension.-100  ml. of anti-Type II pneumo-
coccus  horse serum H 513,1  bleeding Dec.  13,  1938, without  preservative,  were diluted
to 235 ml.  with 0.9 per cent saline warmed  to  370C.  and a solution of 13.5  mg. of Type
II pneumococcus  specific  carbohydrate2 (10)  was  run  in  with  stirring.  After  an  hour
the  floccules  were  centrifuged,  carefully  rubbed  up into  a  thin cream  with  25  ml.  of
saline, and washed  five  times  at  370C.,  with  centrifuging,  until  supernatants  yielded
a  constant  minimal  precipitate  on  boiling.  The  specific  precipitate  was  then  finely
ground with additions  of saline,  and made up with saline to 175 ml.  Merthiolate 3 was
added to a final concentration of 1:10,000.  The resulting suspension contained 6.96 mg.
of protein  per  ml.,  or  1.10  mg.  of antibody N,  corresponding  to an  average  antibody
N/S II ratio of 14.3  in the precipitate.  Two lots were prepared  in this way.
Rabbits  were  injected  intravenously  with  the  suspension,  at  first  in  diluted  form.
Doses of from 3.4  to 10 mg. of protein were  given four timesweekly for the first  eleven
injections.  The  first  bleeding  was  taken  7 days  after  the  last  injection.  A  second
course of eight injections, of from 1.7 to 5.0 mg. of protein, was followed by a rest period
of a week,  after  which  the  rabbits  were bled  out.  The  serum  was  preserved  by  the
addition  of  1:10,000  of  merthiolate.3 All experiments  were  made  with a  1:1  dilution
of this serum with saline, neutralized  to pH 6.9 or 7.0.
Preparation  of  Test  Antigen  Specific  Precipitate Suspensions.-After precipitation
with  the  appropriate  polysaccharides  or  antigens all suspensions  were  carefully  rubbed
up into thin creams and  washed with 0.9 per  cent  saline until supernatants  showed  no
precipitate  or only a  slight constant turbidity  on boiling.  Usually about  five  washings
sufficed.  The  precipitates  were  uniformly  suspended  in  saline  containing  1:10,000
merthiolate.  The antibody N/antigen ratio was calculated from the amount of antigen
used,  the volume  of  suspension obtained,  and the nitrogen analysis,  for all antigen  was
assumed to be precipitated  as its amount was chosen in each instance so that an excess of
antibody remained  (cf.  11).
1  Obtained  through the courtesy of Dr. A.  B. Wadsworth and Dr. H. W. Lyall of the
New York State Department of Health Laboratories.
2 Subsequently referred to as S, with the appropriate type numeral.
3  Manufactured by Eli Lilly and Company, Indianapolis.
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Precipitate  (a):  S II-anti-S II specific precipitate  with high antibody  N/S II ratio:
1.32 mg. of S II were added at 37C. to a dilution of  18 ml. of horse serum H 513.  Ratio
antibody  N/S II  =  10.8.
(b) S II-anti-S II specific precipitate  of lower ratio:  2.67  mg. of  S II and  20 ml.  of
serum H 513 were used.  Ratio  =  6.7.
(c) S I-anti-S  I  specific precipitate  with  higher antibody  N/S I ratio:  3.92  mg. of
S I were added to 50 ml. of Type I anti-Pn4 horse serum diluted with 150  ml. of saline,
at room temperature,  then left at 0°C. overnight.  Ratio of antibody N/S I  =  8.8.
(d)  S I-anti-S  I specific  precipitate  of  lower  ratio:  2.41  mg. of  S I and  15  ml.  of
serum used.  Ratio  = 4.0.  Another suspension with a ratio of 5.1 was also used.
(e) Pn  C-anti-C specific  precipitate of higher antibody  N/Pn  C  ratio:  4 mg.  of C
substance  (12)  derived  from the Type I pneumococcus  were  added to 350  ml. of  Type
VIII anti-Pn horse serum H 9095 at 0°C.  Ratio approximately  6.
(f)  Pn C-anti-C  specific  precipitate  of lower  ratio:  To the supernatant  serum from
(e) was added an additional  14 mg. of  C substance.  Ratio approximately 2.
(g) Haemophilus  influenzae, type B-anti-influenza  (horse)  specific precipitate:  75 ml.
of anti-influenza,  type B, horse serums  were  diluted to 112 ml.  with saline and precipi-
tated with crude H. influenzae type B polysaccharide  (13).
(h)  Diphtheria  toxoid-antitoxin  (horse)  floccules:  690 ml. of crude toxoid 5 contain-
ing approximately  32  Lf per  ml.  were  stirred  into  15.5  ml.  of  horse  diphtheria  anti-
toxin  containing  1480  units  per  ml.  After  1  hours  at  42-45°C.  the  solution  was
left in the ice box overnight,  warmed  again  at 42°C.  for an  hour, and then centrifuged
at 3,000 R.P.m. for several hours.  Yield of washed suspension, 32 mg. N.
(i) Ea7-anti-Ea  (horse)  specific precipitate:  33  ml. of horse antiserum  to crystalline
egg albumin s (14,  15)  were diluted with saline to 110 ml.  and 1.28  mg. Ea N added, at
0°C.  Ratio antibody N/Ea  N  =  7.5.
Other Specific Precipitate  Suspensions.-Specific precipitates were prepared from anti-
Pn II  rabbit  serum  and  from anti-Pn  I pig  serum.  Both  were  tested  quantitatively
against the anti-specific precipitate  rabbit serum but carried down no nitrogen.
Type II  Antipneumococcus Horse Antibody Solution.-93.5 ml. of antipneumococcus
horse serum H 513 were diluted to 250 ml. with saline and 24.5 mg. of S II added at 37C.
After  1  hours  the precipitate  was  centrifuged  and  washed  five  times.  It  was  then
dissociated for 45 minutes at 37°C.  with 10 per cent sodium acetate solution, a modifica-
tion of the procedure used  in  (16).  The precipitate  was centrifuged  off, and the super-
natant dialyzed against 0.9 per cent saline.  Precipitin antibody N/total N in solution  =
76 per cent.
Type I A ntipneumococcus Horse Antibody Solution.  9-A  similar preparation was made
4 Pn used for pneumococcus.
5  Kindly supplied by Dr. R. H. Muckenfuss  of the New  York City Board of Health
Laboratories.
6  Supplied to Dr. Hattie E. Alexander through the courtesy of the Serum Laboratory
of the Massachusetts  State Board of Health.
7  Ea used for crystalline egg albumin.
8  Obtained through the courtesy of Dr. A. M. Pappenheimer, Jr.
9  Prepared  in this laboratory by Dr. Bertil Josephson  of the Caroline  Medical  Uni-
versity,  Stockholm,  Sweden.
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from a Type I antipneumococcus  horse serum by dissociation with  10 per cent K2HPO4
solution.  Purity  =  77  per cent.
Analytical Procedure.-Varying  amounts of the suspensions of the test antigen specific
precipitates,  of  known  nitrogen  content,  were  measured  out with  calibrated  pipettes
into 1.0  ml. of the rabbit  antiserum against  Pn II  horse specific precipitate at 0°C.  In
TABLE  I
Precipitation of  Rabbit Anti-Pn II  Horse Specific Precipitate Serum  by  Pn II  Specific
Precipitates, at 0°C., 48 Hours, per 1.0  Ml. of Serum
Suspension  N added  Total N pptd  Antib  N  pptd.  Antibody N
mg.mg.  mg.
Test antigen:  Horse  anti-Pn II sp. ppt.,  ratio antibody N/S II =  10.8
0.448*  0.760  0.312  0.70
0.672*  1.078  0.406  0.60
0.896*  1.352  0.456t  0.51
1.120*  1.614  0.494:  0.44
Test  antigen:  Horse  anti-Pn  II  sp.  ppt.,  ratio  =  6.9
0.636  0.974  0.338  0.53
0.954  1.372  0.418  0.44
1.272  1.756  0.484§
1.590*  2.070  0.480§
Same  test  antigen  resuspended  after  8  mos.  in  ice  box
0.1921  0.314  0.122  0.64
0.288**  0.464  0.176  0.61
0.384tt  0.591  0.207  0.54
0.576  0.810  0.234  0.41
*Single  determination  only.
t Supernatant  yielded 0.05  mg.  N  with  a high  ratio horse  Pn I  specific  precipitate
suspension.
I From an aliquot portion of the supernatant,  antigen in excess precipitated  N equiv-
alent to 0.024 mg. on the entire supernatant,  or 0.521  mg. total antibody N.
§ Supernatants  yielded no more antibody to a high ratio horse Pn I specific precipitate
suspension.
I[  Triple  quantities of antigen and serum were  actually used for analysis.
**  Double quantities actually  used for  analysis.
It  One and one-half quantities"  "  "
the region  of antibody  excess, multiple  quantities  of both antigen  and antiserum  were
usually used for greater accuracy.  The tubes were allowed to stand for 48 hours at 0°C.,
with occasional mixing, and were washed twice with saline, and the precipitates analyzed.
The  difference  between  the total nitrogen brought  down and the antigen  nitrogen used
was taken as antibody nitrogen  (Tables I to VI, VIII, IX).  This procedure is essentially
that of the quantitative  agglutinin method (9),  with specific precipitates substituted for
bacterial  suspensions.  The  determinations  with  soluble  antigens  were  made similarly
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TABLE II
Precipitation  of Rabbit Anti-Pn  II  Horse Specific Precipitate Serum  by  Pn I  Specific
Precipitates,  at 0OC., 48 Hours, per 1.0 Ml. of Serum Used
Suspension  N added  Total N pptd.  AntibydN pptd.  Antibody N (byd  umerece)  Antigen N
mg.  mg.  mg.
Test  antigen:  Horse  anti-Type  I  pneumococcus  sp. ppt.,  ratio antibody  N/S  I  =  8.6
0.172*  0.342  0.170  0.99
0.344t  0.629  0.285  0.83
0.688  1.120  0.432  0.63
1.032  1.510  0.478  0.46
1.376  1.876  0.500
2.064t  2.560  0.496§
Test  antigen:  Horse  anti-Type  I  pneumococcus  sp.  ppt.,  ratio  =  4.0
0.222t  0.343  0.121  0.55
0.444  0.636  0.192  0.43
0.888  1.254  0.366  0.41
1.776:  2.224  0.448  0.25
* Quadruple  quantities actually used for analysis.
t Double  quantities  "  "  "  "
t  One-half quantities  "  "  "  "
§ Analysis of supernatant gave no more antibody.
TABLE  III
Precipitation  of Rabbit Anti-Pn II  Horse Specific  Precipitate Serum  by  Pn C-Anti-C
Precipitates,  at 0OC., 48 Hours, per 1.0 Ml. of Serum Used
Suspension N added
mg.
Total N pptd. Antibod  N pptd.
(by difference)
Mg.
Antibody N
Antigen N
Test antigen:  Pn C-anti-C sp. ppt. from a horse anti-Type VIII pneumococcus  serum,  ratio
antibody N/Pn C =  5.9
0.091*  0.315  0.224  2.5
0.137t  0.410  0.273  2.0
0.195t  0.632  0.437§  2.2
0.390  0.894  0.50411
Test antigen:  Pn C-anti-C sp. ppt. from a horse anti-Type VIII pneumococcus  serum,  ratio 1.9
0.281  0.726  0.445  1.6
0.375  0.849  0.474  1.3
0.750  1.258  0.50811
* Triple quantities of antigen and serum actually used for analysis.
t Double quantities actually used.
I One and one-half times this quantity actually used.
§ Supernatant gave 0.064 mg. N with high ratio Pn II specific precipitate suspension.
II Supernatant added no more antibody N to a high ratio horse Pn II  specific precipi-
tate  suspension.
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by  the  quantitative  precipitin  method  (17).  Excess  antigen  in the  supernatants  was
determined as previously  described  (18).
Experiments with Anti-Pn II  (Horse) Specific Precipitate  Rabbit Serum
after Absorption with  Ea-Anti-Ea (Horse) Specific  Precipitate.-
To 24 ml.  of  1:1 diluted anti-Ea  horse serums (14,  15)  there was  added 0.84 mg. of
Ea N, an  amount well within the  flocculating  range.  The precipitate  was  allowed to
stand  for 24 hours  and  was  then centrifuged  off,  washed  five  times with  0.9  per cent
saline,  and resuspended  in saline.  The yield  was  11.2  ml.  of  a  suspension  containing
TABLE  IV
Precipitation of Rabbit  Anti-Pn II  Horse Specific  Precipitate Serum  by  Haemophilus
influenzae, Type B Specific Precipitate,  at O0C., 48 Hours, per 1.0 Ml. of Serum Used
Suspension N  added  Total N pptd.  (by  i  erence  Antibody N
mg.  mg.  mg.
Test antigen:  Horse  anti-H.  infuenzae type  B  sp.  ppt.  susp.
0.086*  0.242  0.156  1.8
0.115t  0.307  0.192  1.7
0.172$  0.422  0.250  1.5
0.344§  0.756  0.412  1.2
0.516  1.002  0.486  0.94
0.688  1.214  0.52611
* Quadruple quantities actually  used.
t Triple  ..  .
I Double  "  "  "
§ One and one-half "  . "
1I  Supernatants  added no  more antibody  N  to a high  ratio  Pn I specific  precipitate
suspension.
0.588 mg. N per ml.  10 ml. of the suspension were added to 10 ml. of the anti-specific
precipitate  rabbit  serum and left for 48 hours at 0°C. with  occasional stirring.  It  was
calculated  (Table V)  that this  quantity  of precipitate  N  would remove all of the anti-
bodies  reactive  with  this  precipitate.  After  centrifugation  the  absorbed serum  was
set up with a  high ratio Pn I specific  precipitate suspension, except  for the first point,
for  which  a similar  Pn II  suspension  was  used.  The  results,  given  in Table  VI,  are
calculated to an antibody N content of 0.50 mg.  per ml. for comparison  with 1.0  ml. of
the  unabsorbed  serum.
Experiments with Pepsin-Digested Type I  Antipneumococcus Horse Anti-
body.--
100 ml. of Type I antipneumococcus  horse serum were absorbed with Pn C substance
derived from  Pn II  organisms.  In order  to start with  partially  purified  Type I anti-
body  the supernatant  serum was first  precipitated by  dialysis  for  4  days  in  the  cold
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Precipitation of Rabbit Anti-Pn II  Horse Specific Precipitate  Serum by  Various Specific
Precipitates,  at O0C., 48 Hours, per 1.0 Ml. of Serum Used
Suspension N added  Total N pptd.  A(ibqy  dN  pptd.  Antibody N
Antigen N
Ing.  Ig.  mg.
Test  antigen:  Horse  anti-crystalline  egg  albumin  sp.  ppt.  susp.,  ratio  5.6
0.076*  0.228  0.152  2.0
0.lOlt  0.277  0.176  1.7
0.151$  0.360  0.209  1.4
0.159§  0.363  0.204  1.3
0.20111  0.408  0.207  1.0
0.239§  0.455  0.216  0.90
0.302$  0.535  0.233  0.77
0.478§  0.728  0.250
0.604  0.862  0.258
Test  antigen:  Toxoid-antitoxin  tfoccules  from  horse  anti-diphtheria  serum
0.242$  0.471  0.229  0.95
0.483  0.744  0.261  0.54
0.966  1.246  0.280  0.29
1.449  1.760  0.311**
* Quadruple quantities of antigen  and serum actually used.
t Triple quantities actually used.
t Double quantities  "  "
§ These values are from an earlier experiment with the same antiserum and a specific
precipitate with the same ratio and indicate the close reproducibility of the data.  Single
determinations  were  run in this series.
II  One and one-half quantities actually  used.
**  Supernatants  added  no  more  antibody  N to toxoid-antitoxin  floccules but gave
0.04  mg.  antibody  N  to  Ea-anti-Ea  (horse)  specific  precipitate  (0.25  mg.  N),  cal-
culated  to  1.0  ml.  serum;  further  complete  absorption  with  high ratio  Pn C-anti-C
(Pn VIII)  specific  precipitate  yielded  an  additional  0.16  mg. antibody  N.  Total re-
moved from  1.0 ml. serum was 0.51 mg. antibody N.
TABLE  VI
Addition of Anti-Pn I  and Anti-Pn II  Horse Specific Precipitate  Suspensions to  Rabbit
Anti-Pn  II  Horse Specific  Precipitate Serum  Absorbed  with  Ea-Anti-Ea
(Horse)  Specific Precipitate Suspension; O0C.,  48 Hours.  Calculated
to  0.5 Mg. Antibody N, for Comparison  with  Unabsorbed Serum
Antigen N added  Total N pptd.  Antiby  N  pptd.  Antibody N
(by difference)  Antigen N
mg.  Mg.  mg.
0.233*t  0.368  0.135  0.58
0.584*1:  0.921  0.337  0.58
0.715*1:  1.094  0.379  0.53
1.078:  1.552  0.474
1.430$  1.909  0.479
* Single determination only because of limited amount of serum.
t  High ratio Pn II specific precipitate suspension used.
"  "  Pn I  "  "  "  "
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TABLE  VII
Precipitation of Rabbit Anti-Specific  Precipitate Serum by  Purified Horse Antibody
Solutions, per 1.0 MI. Rabbit Serum, O0C.,  48 Hours
Antigen N  Antigen N  Total N pptd.  Antibody N  Antibody N
added  pptd.  pptd.  Antigen N  Tests on supernatants
mg.  mg.  mg.  g.
Test  antigen:  Salt-dissociated  antibody  solution  from  anti-Pn  II  horse  serum
0.020  Total*  0.185  0.164  8.0  Excess RAt
0.041  "  0.335  0.294  7.2  "  "
0.082  "  0.506  0.424  5.2  "  "
0.124  "  0.626  0.502  4.0  No Ra or Hat
0.247  0.2441  0.782  0.538  2.2  Slight excess HA
mg. antibody N
mg. antigen  N  pptd  =  10.9  - 19.5  /antigenN mg. antigen  N
Test  antigen:  Salt-dissociated  antibody  solution  from  anti-Pn  I  horse  serum
0.0276  Total*  0.235  0.207  7.5  Excess RA
0.055  0.374  0.319  5.8  " 
0.083§  0.480  0.397  4.8  "  "
0.110  "  0.560  0.450  4.1  "  "
0.138  "  0.614  0.476  3.5  No Ra or Ha
0.165  "  0.658  0.493  3.0  "  ""  i 
0.193  "  0.702  0.509  2.6  Trace HA
mg. antibody  N  , mg.  antibody  N pptd.  9.93 - j17.3  VantigenN
mg. antigen  N
* Assuming all N of the purified horse antibody solution to be precipitable by an excess
of the antiserum.
t  RA  = rabbit antibody.  HA  horse antibody used as antigen in the experiment.
$ From analysis  on supernatant.
§ Double quantities of antigen and serum used.
TABLE  VIII
Precipitation of  Rabbit Anti-Specific  Precipitate Serum  by  Specific  Precipitates from
Undigested and Digested Antibody, per 1.0 Ml. Serum, O0C., 48 Hours
Suspension N  used  Total N pptd.  Antibody N pptd. (by difference)
mg.  mg.  mig.
Test antigen:  Sp. ppt. from undigested Pn I horse antibody soln.
0.244  0.596  0.352
0.488  0.991  0.506
Test antigen:  Sp. ppt. from  digested  Pn I horse antibody soln.
0.368  0.721  0.353
0.736  1.199  0.463
1.104  1.603  0.499
132HENRY  P.  TREFFERS  AND  MICHAEL  HEIDELBERGER
against  0.029 M  phosphate  buffer at pH 6.8, a method essentially  that of Felton  (19).
The  precipitate  was  collected,  washed  with  cold buffer solution,  and redissolved  in  50
ml. of 0.9 per cent saline.
Pepsin was partially purified, but not crystallized, according  to (20).  25 ml.  of the
antibody solution were adjusted to pH 4.70 with HC1,  cooled to 0°C., and 2.5 ml. of the
pepsin solution (6.15  mg. N per  ml.) added  (cf. 21).  An immediate precipitate formed.
The mixture  was allowed to stand at 0°C.  with frequent stirring  for  5  hours and was
then neutralized  to pH 7.0 to destroy the enzyme.  20 ml. of the partially digested anti-
body  solution  were  precipitated  with  1.2  mg.  of S I, and  the  specific precipitate  was
thoroughly washed before being made up into a test antigen suspension.  Ratio antibody
N/S I = 6.1.  As a control, 3.9 ml. of the undigested antibody solution were precipitated
with  0.57  mg.  of S I.  The  specific  precipitate  was  washed  and  resuspended.  Ratio
N/S I  =  6.2.  Both  the "digested"  and "undigested"  specific precipitate  suspensions
were used as test antigens against the anti-Pn II (horse) specific precipitate  rabbit serum
(Table VIII).
Qualitative Experiments  with  Anti-Pn  II  (Horse)  Specific  Precipitate
Rabbit Serum.-
1. Several drops of anti-Pn II horse serum were added to a relatively large amount  of
the anti-specific precipitate rabbit serum.  This left in solution an excess of rabbit anti-
body  but precipitated all of the Pn II antibody in  the horse serum added,  since  a test
portion  of  the supernatant  did not agglutinate  a Pn II bacterial  suspension  even after
several  hours.  The  original precipitate  was washed and  evenly resuspended  in  saline.
When a few drops of 1  :10,000 S II solution were added reagglutination took place (cf. 22 a),
the precipitate settling  much more  rapidly than a control  suspension without polysac-
charide.  The effect could be greatly enhanced by substituting a washed Pn II bacterial
suspension for the polysaccharide.
2.  0.5  ml.  of anti-Ea  horse  serum  was  precipitated  with  0.02  mg.  of Ea  N.  The
precipitate  was washed  five times with saline.  0.2 mg. Ea N was then added; complete
solution  of  the precipitate  required  about  2 days.  One  drop  of  this  inhibition  zone
solution added to the anti-specific precipitate rabbit serum gave immediate precipitation.
A control tube with the rabbit serum and Ea alone was negative.
3.  A  guinea pig was  preparedly with an  intraperitoneal  injection  of 0.20  ml.  of un-
diluted  anti-Pn II  (horse)  specific  precipitate  rabbit  serum.  24 hours  later  an  intra-
venous injection of 0.15 ml. of Pn I rabbit antiserum was given.  There were no reactions
up to 25 minutes.  A  second  injection of 0.20  ml. of Pn II rabbit  antiserum was  then
administered  again  without  result  for 25  minutes.  Finally  0.12  ml.  of  normal  horse
serum were given intravenously.  Within a minute the animal showed typical  anaphy-
lactic signs, with respiratory  difficulty and dilated pupils.  Paralysis and death occurred
in 4 minutes.  Control pigs given only an intravenous injection  of 0.20 ml. normal horse
serum or anti-precipitate rabbit serum showed no signs of injury immediately or after 24
hours.
10 The assistance  of Dr. Joseph  C.  Turner  in  this experiment  is gratefully  acknowl-
edged.
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DISCUSSION
One of the greatest drawbacks in the use of serum proteins in immunologi-
cal studies is the heterogeneity of the fractions usually obtained by chemical
or physical means.  This difficulty may be avoided in great part, however,
if  advantage  is  taken  of the immunological  properties  of  antibodies  since
these may be separated from the normal serum proteins or from one another
by  specific  precipitation.  Studies  along  these  lines,  already  explored  in
part by Ando  and  collaborators  (6),  and  by Marrack  and Duff  (7),  have
been carried  out in the present instance with  an immunizing antigen  con-
sisting of  the  specific precipitate  from S II and  an anti-Type  II  pneumo-
coccus horse serum.
The antipneumococcus  horse  serum H 513  used for preparation  of  the
immunizing  suspension  contained  2.24  mg.  of  antibody  nitrogen  per  ml.
by  direct  analysis,  but  only enough  polysaccharide  was added  to precipi-
tate  86 per cent of the antibody.  This resulted in the high antibody N/S
II ratio of  14.3  in the precipitate,  a value about twice that at the antigen
excess  end  of  the equivalence  zone  for this  serum.  The  antibody  in  the
precipitate  could  therefore  still  combine with considerable  S II (see  pages
126,  127).  It seemed  desirable  that  the immunizing  antigen  contain  free
groupings capable of reacting with polysaccharide,  in order to test whether
such reactive  groupings  could  produce  antibodies  in  the  rabbit directed
specifically  toward them.
With  one  exception  specific  precipitates  derived  from  Pn II, Pn  I,  Pn
VIII  (anti-C),  and  H. influenzae  horse  antisera,  when  used  in  excess  as
test antigens, removed the same amount of antibody N, within experimental
error, from the anti-Pn II horse specific precipitate rabbit serum (Table IX).
The amount  of the rabbit antibody N removed  by a given amount of  sus-
pension  N  varied  somewhat  with  each  suspension.  Specific  precipitate
suspensions having  the higher ratios  of antibody N/S were more  effective
per mg. of (horse) protein N in removing antibody from the anti-precipitate
rabbit serum than those of lower ratio (Tables I, II, III).  The total amount
of rabbit  antibody  removed  by  excess  suspension  was  not  affected,  how-
ever,  except  that one  of  the two low  ratio  Pn I specific  precipitates  used
removed only 64 per cent of the total antibody  present  (Table IX).  It  is
not yet possible  to state whether  the decrease in the antibody  N removed
per mg. of suspension N of lower ratio added is due to actual  combination
of the larger quantities  of S or antigen with groupings antigenically  active
toward  the  anti-precipitate  rabbit  serum,  or  whether  such  groupings  are
sterically  shielded  and  prevented  from  reacting  by  the combination  of  S
or antigen  with neighboring  groupings possessing only  antibody  function.
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A noticeable decrease  in the antibody N/antigen N ratio occurred  in the
reaction  of the lower ratio Pn II specific precipitate  suspension with anti-
precipitate  serum  when  repeated  8  months  after  preparation  of  the sus-
pension  (Table  I).  This effect,  which might  be due  either  to changes  in
physical  state or to intermolecular  rearrangements,  may be  related to the
greater  difficulty  with  which  some  precipitates  dissolve  in  excess  antigen
after  aging  (23).
The Pn C-anti-C  specific precipitate  suspensions  were  unusually  active
in  precipitating  antibody,  as judged  by  the  ratios  in  the  last  column  of
TABLE  IX
Summary of Maximum Amount of Antibody N Precipitated  from Rabbit Anti-Pn II  Horse
Specific Precipitate  Serum by  Various Antigens,  at O0C.,  48 Hours, per 1.0 Ml. Serum
Maximum  antibody N
Test antigen  (horse)  precipitated per ml.
serum
0M.
Anti-Pn II,  high ratio sp. ppt .......................................  0.52
"  Pn II,  low ratio sp. ppt .......................................  0.48
"  Pn I, high ratio sp. ppt ......................................  . 0.50
"  Pn C, higher ratio sp. ppt .....................................  0.50
"  Pn  C, lower ratio sp.  ppt ......................................  0.51
"  H. inluenszae, type B,  sp. ppt ...................................  0.53
Ea-anti-Ea  sp. ppt .................................................  0.26
Diphtheria toxoid-antitoxin  floccules .................................  0.31
Pn II anticarbohydrate  solution .....................................  0.54
Pn I anticarbohydrate  solution .....................................  0.51
Sp.  ppt. from partially  digested  (pepsin)  Pn I anticarbohydrate .........  0.50
Anti-Pn II (rabbit)  sp.  ppt .........................................  0
"  Pn I  (pig) sp. ppt .............................................  0
Table III.  The viscosity of the C substance  is materially lower than those
of  the  type specific  polysaccharides  of  pneumococcus,  indicating  either a
lower  molecular  weight  or  different  shape.  Either  alternative  might
permit reaction of the  C substance with a larger number of horse antibody
molecules  per  unit  of  weight  used.
The  reaction of  EaT with its antibody in  the horse  is singular in that it
exhibits  the zone  phenomenon  characteristic  of  toxin-antitoxin  reactions
in the horse  (14,  15),  rather  than  the typical precipitin reaction  given by
Ea-anti-Ea  in  the  rabbit  (11).  Like  diphtheria  antitoxin,  antibody  to
Ea  in the  horse  is  largely in  the water-soluble  pseudoglobulin  fraction  in
contrast  to the  other,  water-insoluble,  horse  antibodies  employed  in  this
work.  It  might  be  expected,  therefore,  that  the  specific  precipitates  of
these two  classes of proteins  should exhibit  differences  in  behavior  toward
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the anti-Pn II horse specific precipitate rabbit serum.  Thus the Ea-anti-Ea
specific  precipitate  removed  only  51  per  cent,  and the  diphtheria  toxoid-
antitoxin  floccules  61  per  cent  of  the  rabbit  antibody  taken  out  by the
pneumococcus  specific  precipitates  (Tables  V,  IX).  That  the  first  two
antigens  remove  essentially  the  same  antibodies  is further  demonstrated
by the failure of Ea-anti-Ea specific precipitate to combine with appreciable
antibody in  rabbit  anti-Pn  II  specific  precipitate  serum  which  had  been
absorbed  with  toxoid-antitoxin  floccules  (Table  V,  footnote).
Moreover,  the antibody N removed from the antiprecipitate  rabbit serum
by the Pn C-anti-C  specific precipitate alone  (Table III) equalled  the sum
of that precipitated by toxoid-antitoxin floccules  (Table V) and the portion
subsequently  recovered  from  the  supernatant  with  Pn  C-anti-C  specific
precipitate  (Table V, footnote),  showing that the antibodies which combine
with the water-soluble protein group also form  a part of those uniting with
the water-insoluble  group and differ only in cross reactivity.
The  narrow  flocculating  limits  of  the antitoxic  type  of  reaction  do not
permit  the  preparation  of  specific  precipitate  suspensions  of much  higher
ratio than those  of  the equivalence  zone.  That the lower  amount  of anti-
body  nitrogen  removed  by  specific  precipitates  derived  from  the water-
soluble proteins (Table V) is not merely  a low ratio effect is indicated, how-
ever,  by other  evidence.  The  experiments  of  Ando  and  his collaborators
(6) show distinct antigenic differences between their water-soluble A group,
of which  the  antitoxic antibodies  form  a part, and  the water-insoluble  B
group which  contains the antibacterial  antibodies.  Furthermore,  Marrack
and  Duff  (7)  have  found  that  water-soluble  pseudoglobulin  from  horse
serum  precipitated  less  antibody  from  anti-specific  precipitate  rabbit
serum  than  did  the  water-insoluble  euglobulin.  When  their anti-specific
precipitate  serum was  absorbed with pseudoglobulin,  the supernatant still
gave a positive test with euglobulin, whereas absorption of the serum with
euglobulin  removed  all  of  the  antibodies  to  pseudoglobulin,  although  a
positive  test was  still  obtained  with  a salt-dissociated  antibody  solution.
The quantitative  course  of  the  reaction  of  the  anti-specific  precipitate
serum with various  specific precipitates  (Tables I to V) or with dissociated
antibody solutions  (Table  VII) may be represented  by the linear equation
AntigebodyN  in the precipitate  =  3R"  -
2 (R")(A
i ge n N)
in which 3R" is the intercept on the y axis and the last term on the right is
the slope  of  the line,  A  =  maximum precipitable  antibody  N,  and R"  =
antibody  N/antigen  N  ratio  at  the  maximum.  This  empirical  equation
has  been  found  to  represent  quite  accurately  the  behavior  of  anti-dye
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sera (24)  and certain anti-egg albumin sera (11).  When the ratio antibody
N/antigen  N in  the precipitate  was plotted against the square  root of the
amount of antigen  N precipitated,  the data fitted  closely to straight lines.
Except for the C-anti-C suspensions  this relation also held  in the present
study.  The intercepts  on the y  axis,  3R",  had  values  ranging from  0.68
for the  low  ratio (4.0)  Pn  I specific  precipitate  suspension,  to 3.5  for the
horse  anti-Ea  system.  The  corresponding  slopes  were  -0.31  and  -5.6
respectively.  The  constants  for  the  soluble  antigens  were  somewhat
larger, as might have been expected  owing to the change in physical state
of the antigen.
From the data and equations in Table VII it will be noted that the anti-
genic  behavior  of the  Pn I antibody  solution  is  almost  indistinguishable
from  that of  the  Pn II  antibody  solution.  Although  only a  few  points
in the region  of antibody excess  are available  in  the data of  Marrack  and
Duff  (7),  the agreement between  the constants for their antibody solution
and ours is of the expected order for two different sera  (cf.  11).
After  absorption  with  Ea-anti-Ea  (horse)  specific  precipitate  and  re-
moval  in  this  way  of  roughly  one-half  of  the  antibody  the  anti-specific
precipitate  rabbit  serum  still  resembled  the  unabsorbed  serum  in  its
quantitative  reactivity  toward  a high  ratio  Pn  specific  precipitate  when
compared  at the same antibody  content (Table VI,  also Table II).  These
results, while necessarily subject  to a greater experimental  error than those
on the  cross reactions of S III and S VIII with anti-Pn  VIII and anti-Pn
III horse sera (25), point to the same conclusion that absorption with a cross
reacting  antigen may leave  the remainder of the antibody  with unchanged
reactivity  toward  the  homologous antigen  as judged  by  the antibody  N-
antigen  curves.  In these cases  the cross  reaction  removed  essentially  an
average  sample  of  the  homologous  antibody.
The  coexistence  of  separate  groupings  which  function  as  antigen  and
antibody on the same molecule of horse globulin is indicated by experiments
showing  that Pn  II horse  antibody  precipitated  with  an  excess  of  anti-
specific  precipitate  rabbit serum  can still combine with S II, and  that the
horse antibody  in  a solution of  the Ea-anti-Ea  (horse)  specific  precipitate
in  an  excess  of  Ea  still  reacts  with  the  anti-specific  precipitate  rabbit
serum  (page  133).  This  accords  with  and  extends  earlier data  on other
systems  (26).
Although  all  of  the  antigens  used  in  the  form  of  specific  precipitates
(Tables I to VI)  and  antibody  solutions  (Table VII) were  horse proteins,
each had at the same time the unique property,  as an antibody, of reacting
specifically  with  an  antigen.  It  was  therefore  of  interest  to  examine
whether this  antibody specificity  would  affect  in any  way  their function
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as test  antigens.  It  has not been  possible,  however,  to demonstrate  any
variation  due to the type specific antibody groupings either by the sensitive
quantitative  agglutinin  method  or  by  passive  anaphylaxis  tests  in  the
guinea  pig.  The  anti-Pn  II  horse  specific  precipitate  rabbit  serum  was
also  tested  with  a  specific  precipitate  derived  from  a Pn II rabbit  anti-
serum  (Table  IX).  There was no addition  of antibody N, indicating  that
the anti-precipitate  serum contained  no antibody which  would  cross react
with an antigen  containing an antibody grouping  specific for S II.  A test
similar to that with Pn II rabbit serum specific precipitate was also carried
out with a  specific  precipitate prepared  from a Pn I pig  antiserum  (Table
IX)  and  yielded  negative  results.  Although  no  information  could  be
obtained from  this antigen  concerning  cross  reactions due to Pn type spec-
ificity,  there was  a  possibility that there might be a cross reaction  due  to
the  similar  sedimentation  constants  and  molecular  weights  (27)  of  Pn
anticarbohydrate  from pig  and horse  antisera.
The  antigenic  reactions,  then,  of  this  representative  water-insoluble
group of antibodies engendered in the horse are essentially similar  (Tables
I to IV), when due allowance is made for the effect of the amount of antigen
combined in the test  antigen specific precipitate  suspension.  In addition,
each  suspension  removed  the  same  total amount  of  antibody  as  did  two
types  of  purified  pneumococcus  antibody  solutions  (Table  IX).  The
antigenic  activity  of  the antibodies  studied appears  therefore  to be  solely
that of  a particular  fraction  of horse  serum globulin.  This confirms  in  a
more rigorous quantitative manner  Ando's conclusion  (6)  that the various
antibacterial antibodies in the horse are closely related antigenically.  More-
over, the  agreement  between  the results  with  specific  precipitate  suspen-
sions  and  the  corresponding  antigens  in  solution  confirms  anew  the  rig-
orous specificity  of  the analytical methods used, and their lack of depend-
ence  on  the physical  state  of  the  antigen  (cf.  22 b).
Since it has been shown  (21) that partial peptic digestion of antipneumo-
coccus  horse  serum  results  in  an  increase  in  the  combining  power  of  the
antibody  (lower  antibody  N/S  ratio,  or  more  S per  unit of  antibody)  it
was  of  interest  to  compare  the  properties  of  a  specific  precipitate  made
from digested antibody with those of a specific precipitate  suspension of the
same  antibody  N/S  ratio  prepared  from  the  untreated  antibody.  Our
results on the combination of  digested antibody with polysaccharide  were
similar  to those reported  by Grabar  (21).  It  may be noted, however, that
the extrapolated initial combining ratio (17)  of the undigested antibody with
the specific precipitate suspensions was 13 and that of the digested antibody
was  7.5.  To provide  a basis for  comparison,  an antibody  N/S  I ratio  of
6.1 was chosen  in the preparation  of the specific precipitate suspensions  for
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both digested  and undigested  antibody.  As is  readily  seen  (Table  VIII)
less of the specific precipitate  from the undigested antibody was  necessary
to exhaust the anti-specific precipitate  rabbit serum,  but the total amount
of  antibody  removed  was  the  same when  an  excess  of  either  suspension
was used.  While the antibody function of the horse protein was evidently
modified by the digestion,  and the ratio of  antibody N to antigen  N was re-
duced in the reaction with anti-precipitate rabbit  serum, the digested pneu-
mococcus  anticarbohydrate  still  retained  completely  the horse  specificity
function,  or  functional  groupings  necessary  for  complete  removal  of  the
anti-precipitate  rabbit  antibody  (for related  observations with diphtheria
antitoxin  cf.  28,  29).  It may  be noted,  too, that the change  in  antibody
activity  of the  digested  serum is in  the direction  of  an apparent increase,
per weight unit, in  the number of groupings  available for reaction with  S,
while the  reaction of  the corresponding  specific precipitate  with the anti-
precipitate  rabbit serum  indicates  an apparent decrease  in  the number  of
antigenic groups per weight unit.  While  differences  in the physical  state
of the precipitates from digested and undigested  antibody might be wholly
or  in part  responsible  for this effect,  it would  still be  in  accord  with the
assumption  that the  two sets  of groupings,  those functioning  as antigens,
and those acting as antibodies,  are independent  (cf.  also 29).
SUMMARY
1. Rabbits were injected with the washed specific precipitate  from Type
II  antipneumococcus  horse  serum.  Antibody  in  the  resulting  antiserum
was  determined  by  the  quantitative  agglutinin  method  using  various
specific  precipitates  as antigens.
2.  Suspensions  of Types I and II antipneumococcus  horse  specific  pre-
cipitates,  as well  as  the specific  precipitates  derived  from  Type  VIII  Pn
(anti-C  portion),  and  H. influenzae horse  antisera  were  found to  remove
the same amount of antibody from the immune rabbit serum.
3. Purified  antibody  solutions  prepared  by  dissociation  methods  from
Types I and II antipneumococcus horse sera were found to remove the same
quantity of  antibody as did  the homologous  specific  precipitates.
4.  Specific  precipitates  from  anti-crystalline  egg  albumin  and  anti-
diphtheria horse sera were found to remove only a fraction of the antibody.
The  reasons  for  this  are  discussed.
5.  A  specific  precipitate  prepared  from  pepsin-digested  Type  I  anti-
pneumococcus horse serum  removed all of the antibody to the homologous
antigen  from  the  rabbit  anti-precipitate  serum,  but  followed  a  different
quantitative  course.
6.  From the quantitative  course of these reactions and from experiments
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with  specific  precipitates  from anti-Pn  rabbit and pig sera it is concluded
that  the  only  antigenic  specificity  demonstrable  for  the  antibodies  in-
vestigated  was  that due  to  their  common  origin,  and  that the  groupings
responsible  for their antibody function constitute either  a small part of the
total  protein  molecule  or  else  are  non-antigenic.
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